The report takes the reader through a comprehensive review Generic
Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Generic
Pharmaceutical partnering deals.
"FDA is encouraging the generic
industry to investigate whether, and under what circumstances, such problems occur.
On the other hand, generic
medicines are a copy of the formula of the originators and are sold at lower rates as they do not carry out any research work.
As with Truvada, generic
drugs are often substantially cheaper than their branded versions.
About 47.93% of participants agreed that they prescribe generic
medicines when the patient is poor [Figure 3].
Large pharmaceutical companies often spend millions of dollars protecting their patents from generic
3 August 2016 - Irish drugmaker Allergan plc (NYSE: AGN) has closed an agreement under which Israeli generics
specialist Teva Pharmaceutical Industries Ltd.
The global branded generics
market is expected to grow significantly as large number of pharmaceutical products are going to be off patent within the forecast period.
Frittelli said the ZAR4 billion saving was based on 18% of originator drugs having come off patent, allowing generic
drugs to fill the gap and therefore be available for the taking.
Healthcare company Sanofi (EURONEXT:SAN) (NYSE:SNY) revealed on Thursday that it has launched the approved generic
version of Arava (Leflunomide tablets) 10 mg tablets through its US generics
drugs are those not covered by patent protection and are labeled only by their international nonproprietary or generic